President, Chief Executive Officer and Director · ANAPTYSBIO, INC (ANAB)

Hamza Suria

A named executive officer of ANAPTYSBIO in every fiscal year CompBrief holds from FY2016 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,538,858

Salary $586,000Stock awards $0

FY2020: $885,390

1st of 3 named executive officers at Anaptysbio by FY2021 total.

3 named officers on file for ANAPTYSBIO, FY2021

Hamza Suria’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • ANAB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ANAPTYSBIO’s whole pay program stands against its peers

  • ANAPTYSBIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ANAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Hamza Suria’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Hamza Suria compensation by year

ANAPTYSBIO Summary Compensation Table · all 6 fiscal years held
In US dollars, as ANAPTYSBIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021
Salary$425,000$465,000$547,000$567,000$567,000$586,000
Bonus$153,000$0$0$0$0$0
Stock awards$0$0$0$0$0$0
Option awards$0$3,341,588$4,303,927$7,301,646$0$2,702,323
Non-equity incentive$0$209,250$270,765$0$311,850$241,725
Pension and deferred compensation$0$0$0$0$0$0
All other$600$600$540$6,540$6,540$8,810
Total$578,600$4,016,438$5,122,232$7,875,186$885,390$3,538,858

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANAPTYSBIO, INC DEF 14A filed April 29, 2022, accession 0001370053-22-000025, and prior-year filings.

How this page was built: the ANAPTYSBIO, INC filed document, accession 0001370053-22-000025. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$579K
$4.0M
$5.1M
$7.9M
$885K
$3.5M
FY16
FY17
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option27,417—$68.89
Option140,000—$15.73
Option46,300—$29.70
Option1,312—$106.84
Option119,700—$29.70

Per the Outstanding Equity Awards at Fiscal Year-End table in ANAPTYSBIO, INC's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

ANAPTYSBIO’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Hamza Suria · this pagePresident, Chief Executive Officer and Director$3,538,858
Paul LizzulChief Medical Officer$1,699,078
Eric LoumeauChief Operating Officer and General Counsel$1,655,786

The full ANAPTYSBIO compensation record

free company brief

This page is one person within ANAPTYSBIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ANAPTYSBIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hamza Suria's compensation dossier · One-time report. No refunds.